Relationship between the plasma testosterone level and pain reaction times in male rats by Oyekunle, O.A. et al.
НЕЙРОФИЗИОЛОГИЯ / NEUROPHYSIOLOGY.—2009.—T. 41, № 3 231
UDC 577.17+612.884
O. A. OYEKUNLE1, G. FIBIRONKE2, S. F. IGE1, U. S. UDOH1, AND A. K. OKOJIE1
RELATIONSHIP BETWEEN THE PLASMA TESTOSTERONE LEVEL  
AND PAIN REACTION TIMES IN MALE RATS
Received 10.01.09
Male prepubertal (about 4 weeks old) Wistar rats were used to estimate the pain reaction times 
using the tail-flick and hot-plate models; the testosterone concentration in all the animals 
before the tests in the blood plasma was measured. The same sets of animals were kept for 
the next 4 weeks under standard conditions; the experiment was repeated, and pain reaction 
times were also evaluated in the 8-week-old rats with blood samples collected to determine 
the plasma testosterone level. The results showed significant (P < 0.01) increases in the pain 
reaction times in both pain models in pubertal animals observed in a parallel manner with a 
corresponding significant (P < 0.01) increase in the plasma testosterone level. Therefore, age 
and sex are important factors in the choice of animals in pain experiments.
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INTRODUCTION
Expanding literature indicates that gender is an 
important factor influencing the experience of pain. 
Clinical and laboratory observations [1-4] led to a 
general conclusion that females and males noticeably 
differ from each other in their perception and experience 
of pain; females typically showed a greater sensitivity 
to and less tolerance for experimentally induced 
noxious stimulation than males did. Experimental 
and clinical data demonstrated that gonadal hormones 
significantly affect pain-induced responses [4-6]. 
There could be a number of reasons for the differences 
recorded in the pain reactivity between males and 
females, from dissimilar genes to hormonal and 
cultural (in humans) influences. Gonadal hormones 
possess the respective receptors present in many brain 
areas, including some involved in pain transmission 
and modulation. Testosterone as a major gonadal 
hormone in mature males has been known to play a 
protective role manifested, e.g., in adjuvant-induced 
arthritis [7] and in chronic pain stimulation [8]. 
Male rats with a physiological level of testosterone 
recovered better than gonadectomized males with very 
low testosterone levels.
Exogenous testosterone (testosterone propionate) 
injections in male and female rats were found to 
modulate behavioral responses differently in both 
sexes when evaluated with a chronic model of pain. 
This intervention was reported to influence all the 
organization of behavior, decreasing the behavior 
entropy, which is connected with a precipitation of 
the process of inhibition of the exploratory activity 
and emotional reactivity, simultaneously changing the 
dynamics of the behavioral entropy [9].
In this study, we examined the relationship between 
the testosterone concentration in the blood plasma and 
pain reaction times using two pain behavioral tests 
(hot plate and tail flick) in immature and pubertal 
male rats.
METHODS
Two groups, including 8 prepubertal male rats (4 weeks 
old) each, were used in the study. Animals were housed 
under standard vivarium conditions at about 25 ± 
± 1°C with an alternating 12 h/12 h light-dark cycle. 
Food and water were made available ad libitum; all 
experimental manipulations were carried out between 
9.00 and 12.00. The same groups of the animals were 
examined 4 weeks later, i.e., when the animals reached 
the pubertal age.
Hot Plate. Rats were placed on a hot plate maintained 
at 55.5 ± 0.5°C according to the described procedure 
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[10]. The reaction time was measured from the moment 
of placing until either jumping off the plate or licking 
of the hind paw(s). The cut-off imposed for heating 
was 60 sec, to avoid tissue damage [11]. Each rat was 
tested twice, with a 20-min-long interval, and the 
reaction times were averaged.
Tail Flick. The tail-flick reaction was evoked by a 
source of radiant heat focused on the dorsal surface 
of the tail according to the procedure described by 
D’Amour and Smith [12] and modified by Dewey et 
al. [13]. Each rat was tested twice (with a sufficient 
interval), and the reaction times were also averaged 
to obtain a baseline. The cut-off time of 10 sec for 
heating was imposed to prevent tissue damage.
Measuring of the Testosterone Level. Blood samples were 
collected from the middle vein of the ear and centrifuged 
at 3000 rev. min for 3 to 5 min. The testosterone level in 
the blood plasma was measured using standard enzyme-
linked immunosorbent assay (Microwell Method, Dialab, 
Austria) with parallel measurements in the respective 
calibrators attached to the kit. 
RESULTS
In the group of 4-week-old rats subjected to the hot-
plate tests, the level of testosterone in the blood plasma 
was 9.50 ± 0.65 nM, on average. On the 8th week, this 
index increased more than twofold and reached 19.70 
± 1.40 nM (P < 0.01). The mean delay in the reaction 
to noxious thermostimulation in 4-week-old animals 
subjected to the above test was 37.73 ± 1.80 sec. In 
rats reaching the age of pubertation (8 weeks), the 
mean reaction time in this test was 186.90 ± 8.90 sec, 
i.e., it was nearly five times longer than in the first 
measurement (P < 0.01).
The observation made in the tail-flick group 
were quite comparable. The results of testosterone 
measurements were qualitatively the same but 
somewhat differed from the quantitative aspect. In 
the tail-flick group, the mean testosterone level in 
4-week-old animals was 11.20 ± 0.56 nM, i.e., it was 
nearly the same as in the hot-plate group. At 8 weeks, 
this index increased to 39.10 ± 1.90 nM, i.e. an increase 
was noticeably greater than in the former group (more 
than threefold; P < 0.01). Yet, such a difference was 
not unexpected because there was no pre-experimental 
standardization of the animals according to their 
secretion capabilities, and individual variability 
influencing the intergroup mean was quite natural. In 
the tail-flick test, the average reaction time of 4-week-
old animals was 37.75 ± 0.65 sec. In 8-week rats, this 
time increased twofold (74.62 ± 1.25 sec; P < 0.01).
DISCUSSION 
Experimental and clinical data have implicated the presence 
of a sex-hormone factor in most parameters affected 
by painful stimulation [14]. There has been increasing 
evidence that the brain not only respond to hormones 
produced by the reproductive system, but that the levels 
of these hormones, the so-called “female hormone” 
estrogen and progestin and the “male” androgen, such as 
testosterone, play important roles in the perception of pain 
and its modulation [15]. Our investigation focuses on the 
differences in the perception of pain (or pain reaction time) 
in immature and (relatively) mature stages of ontogenesis 
of the same male rats. The initial rather low (nonetheless, 
quite noticeable) testosterone concentrations observed in 
the blood plasma of prepubertal rats in our study are related 
to testosterone produced within this period mostly by some 
other sources than the testes, such as the adrenals [16]. 
The matured male rats well tolerated the stimuli 
in both experimental models of evaluation thereby 
increasing the delays of pain behavioral reactions 
recorded from them [17]. The presence of testosterone 
in a much more significant amount should be 
considered one of the main crucial factors responsible 
for this inhibition (or tolerance) in matured males. The 
observation that testosterone has a protective role is 
supported by earlier demonstrations that this hormone 
can reduce the intensity of nociception by inhibiting 
its inflammation-related component [18]. Our results 
also agree with the results obtained by Aloisi et al. [19] 
and Hau et al. [20] who showed a protective role for 
testosterone in their various studies. In our experiments, 
we observed a quite obvious and close relationship 
between the plasma testosterone concentration and the 
pain reaction times, which is in agreement with earlier 
studies [20], except that our data were collected in same 
animals at different stages of sexual development. Also 
testosterone seems to be responsible for a habituation 
capacity in intact males during repetitive nociceptive 
stimulations, which is lost in castrated males [8]. This 
is also in agreement with our results. 
Of course, the role of other factors influencing 
changes in the pain sensitivity in maturating animals 
should not be underestimated. First of all, this is an 
increase in the mass of the animals and the respective 
increase in the thickness of the skin on the pads and tail 
(accompanied by the improvement of thermoisolation 
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properties). It should, however be taken into account 
that growth of a maturating animal and changes 
in the properties of its skin (to say nothing on the 
peculiarities of the composition and density of somatic 
receptors of different modalities in these tissues) are 
also interlinked hormone-dependent phenomena. 
Different environmental factors and seasonal changes 
also influence, to a certain extent, the parameters of 
pain reactions (both experimental and observed in 
clinics). Nonetheless, the state of the system of the 
mail sex hormone looks as one of the most important 
factors influencing the brain systems of nociception 
and antinociception. As is known, there is abundant 
distribution of testosterone receptors in the brain. 
The roles of endogenous mediators of nociception 
in relation to the testosterone concentration and 
activation of testosterone receptors may be an urgent 
circle of questions for further studies. 
Furthermore, it is important to point out that the role 
of the hormonal background (in our case, testosterone) 
in pain reception has too often been neglected. It was 
reported that testosterone can provide the reduction of 
some clinical pain in both men [21, 22] and women [5].
Finally, our observations highlight the importance of 
taking into account the hormonal status of experimental 
animals when evaluating pain perception and/or pain 
inhibition. Therefore, the choice of experimental 
animals for pain experiments should be based on their 
age and sex rather than on their weight. It should 
be recognized that just the latter aspect has become 
a norm over the years, while the role played by sex 
hormones in pain perception was underestimated. 
Therefore, in some cases using immature animals in 
such experimental studies will be more appropriate.
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Р е з ю м е
У щурів-самців препубертатного віку (чотири тижні) 
вимірювали латентні періоди больових реакцій в умовах 
тестів «відсмикування хвоста» та «гарячої пластинки»; 
у всіх тварин перед тестами вимірювалася концентрація 
тестостерону в плазмі крові. Ці ж самі групи тварин 
утримувалися протягом чотирьох тижнів у стандартних 
умовах, після чого експеримент повторювали на 
восьмитижневих щурах (вимірювали час больових реакцій 
та рівень тестостерону). Для тварин, що досягли віку статевої 
зрілості, було характерне істотне (P < 0.01) збільшення 
латентних періодів больових реакцій в обох використаних 
моделях, що відбувалося паралельно з відповідним 
вірогідним (P < 0.01) збільшенням рівня тестостерону в 
плазмі. Отже, вік і стать є найважливішими факторами при 
відборі тварин для проведення експериментів з больовою 
стимуляцією.
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